Skip Nav

Contact Us

Chondrosarcoma CS Foundation, Inc.

Thank you for your interest in our company. Complete the form below to send us an email, or simply give us a call. We're looking forward to working with you.

  • 301-352-3042

    OK!

    Website for Phase 3 Clinical Trial for Ivosidenib

    Servier Pharmaceuticals has initiated a Phase 3 Clinical Trial for Ivosidenib, an IDH1 biomarker inhibitor. Their clinical trial is for patients diagnosed with conventional chondrosarcoma with advanced metastasis. There are about 30 sites globally that are offering the clinical trial looking for 136 patients.

    They just released a website which provides the details of their clinical trial as well as locations of sites that offer the trial globally.

    For anyone interested the website is https://www.chonquer.com/

    Skip to content